GENEVA, Oct. 1 -- THE CHILDREN'S MEDICAL CENTER CORPORATION filed a patent application (US2026/018915) for “TARGETING LIPID METABOLISM DEFECTS IN NEURODEVELOPMENTAL DISEASES”. With publication no. WO/2026/193276, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 9/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....